Resonance Health commences involvement in diabetes study
Filed with ASX · · 2 pages · English
Earlier from Resonance Health
- Bone Marrow Iron - Regulatory Submission
- Expansion of Involvement in Pharmaceutical Clinical Trial
- HepaFat-Scan International Scientific Journal
- Operational Update
- New UK Standards recommend FerriScan
Later from Resonance Health
- Results Recommending Use of FerriScan in Sickle Cell Disease
- Maylasian NAFLD - Diabetes Study
- Half year report
- Cancer Survivor Campaign Update
- Evidence Building for HepaFat-Scan
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health